Primrose Bio is focused on developing and commercializing its integrated end-to-end technology platform for solving complex drug manufacturing and design challenges.
Primrose's major offerings include Pfenex Expression Technology®: a proprietary production system with up to 20x higher yields, unparalleled success in making complex proteins, and currently used in six approved products; Prima RNApols™: improved enzymes for mRNA manufacturing; and PeliCRM197®: a commercially validated CRM197 carrier protein used for conjugate vaccines.
Several of the world’s leading pharmaceutical companies use Primrose’s technologies, including Merck, Jazz Pharmaceuticals, Alvogen, Serum Institute of India, Arcellx, Arcturus and others.